Fio intelligent devices to automate Ebola rapid test reading and data capture, interconnecting frontline health workers, remote managers, and health organizations

With funding from the Bill & Melinda Gates Foundation, Fio will build on its Fionet platform to strengthen Ebola management in West Africa

TORONTO, CANADA | DECEMBER 09, 2014

Fio Corporation today announced that it has received a grant financed by the Bill & Melinda Gates Foundation to adapt its Fionet™ solution to connect rapid diagnostics and data in the fight against Ebola.

“In an outbreak, it is crucial for health workers to capture data at point of care — if health workers don’t get that data, no one gets that data. It’s equally crucial to treat immediately, on first encounter with the patient — but you can’t treat what you haven’t diagnosed,” said Dr. Michael M. Greenberg, Chairman and CEO at Fio. “Fionet fuses automated data capture with on-the-spot diagnostics. The Gates Foundation is accelerating our capability to be of service in the Ebola crisis.

By integrating intelligent mobile devices for diagnosis, treatment, and data capture with cloud-based information services, Fionet will deliver complete, reliable data within minutes from frontline health workers to remote health managers and organizations responding to the Ebola outbreak.

Automatically reading Ebola rapid tests and connecting it all to the cloud

Only 18 laboratories in West Africa currently have the capacity to test suspected Ebola cases — four in Guinea, nine in Liberia, and five in Sierra Leone It can take days for blood samples to be transported to these centres from patients at triage, and for results to return. Further exacerbated by weak infrastructure, this can mean days in quarantine waiting to get results, increasing the chance of infecting, or being infected by, others.

Several companies are working to bring to market rapid diagnostic tests that can reliably detect Ebola within minutes from a pinprick of blood or sample of saliva. Grant funding will make it possible for Fio’s Deki™ Reader to objectively analyze results from these tests and then immediately transmit results and case reports to the Fionet database.

 

Fio’s Deki Reader will help enable real-time Ebola tracking by providing an automated analysis of rapid test results and immediately transmitting case reports to the Fionet cloud database.
Fio’s Deki Reader will help enable real-time Ebola tracking by providing an automated analysis of rapid test results and immediately transmitting case reports to the Fionet cloud database.

 

 

Patients will get results right away, so they can be instantly isolated, released, or tested for other causes of illness. All this frontline data, available to remote managers via secure online access, will help them make significant gains in containment. In real time, managers will be able to monitor the epidemic, identify hot spots, direct scarce resources and supplies to where they’re most needed, and track potentially infected contacts of patients.

Closing the gap between frontline reality and response

For every new case of Ebola, health workers must track down every person who was in contact with that patient during the preceding days and weeks. Those contacts must then be closely monitored for signs of illness. This is usually accomplished by recording data on paper forms, which are transported to data-entry centres and entered into an electronic database. Even one missed contact can keep the outbreak going.

Grant funding will contribute to the enhancement of Fionet mobile software to supplant this cumbersome process with digital data collection. Health workers will be able to instantly feed contact tracing data to Fionet via smartphones and tablets, reducing time lag between data captured in the field and response. With real-time access to interactive network maps of contacts, managers will be able to quickly identify others who might be infected and begin to arrest transmission.

Lasting value for health system strengthening in West Africa

Many West Africans suffering from diseases other than Ebola, but which also cause fever, are not being treated while awaiting Ebola test results. Fio’s Deki Reader, which will be configured to read Ebola tests, is already CE-marked for use with rapid diagnostic tests that detect malaria and dengue, two common causes of fever in West Africa.

“After adapting Deki Readers and Fionet to combat Ebola, this same technology will leave the health systems in West Africa better prepared to manage future outbreaks, as well as existing endemic diseases,” said Ian Fine, Fio’s Chief Technology Officer.

About Fio Corporation

Operating at the nexus of care delivery and data, Fio is focused on decentralized management of infectious diseases in developed and developing countries alike. Fio helps health workers of all skill levels improve the quality of care they provide to individual patients, while automatically capturing and disseminating data to strengthen health systems as a whole. Fio’s solution combines mobile intelligent devices with cloud information services to create a healthcare delivery solution that drives, rather than competes with, data capture. Fio is headquartered in Toronto, Canada, with commercial operations underway in Latin America, Africa and Europe.

Latest news
Fio showcases remote device connectivity and healthcare management platform at AACC 2016
Fio Corporation is exhibiting its cloud-based connectivity and reporting platform for decentralized [more]
Africare and Fio mark World Malaria Day with innovative new partnership in Nigeria
Launched on World Malaria Day, this collaboration introduces Fio’s integrated diagnostic and data [more]
Malaria Journal findings highlighted on SciDev.net
Following an article published in Malaria Journal looking at how the Deki™ Reader and Fionet™ sy [more]
Take our RDT reading survey
Rapid diagnostic tests (RDTs) allow health workers to offer accurate diagnostic services at the poin [more]
Fio and partners present latest findings at ASTMH 2015 Annual Meeting
Results presented at the American Society of Tropical Medicine and Hygiene’s 64th Annual Meeting h [more]
Public-private collaboration transforms malaria testing and tracking in the DRC
The Ministry of Health in the Democratic Republic of Congo is taking a bold step forward in the figh [more]
Back to top

Privacy         Terms of Use

Copyright Fio Corporation. All rights reserved. Fio is a registered trademark of Fio Corporation. Deki and Fionet are trademarks of Fio Corporation. All other trademarks are the properties of their respective owners. Subject to terms of use. No guarantee or promise of performance is made. Contact us for details on commercial availability. Errors and omissions excepted.